Exact prices its secondary offering


Exact Sciences (EXAS +5.5%) offers 10M shares of common stock at $12.75/share to the public. ~$119.7M net proceeds will fund regulatory approval and commercial activities for Cologuard, other product development efforts and general corporate uses.

Underwriters over-allotment is 1.5M shares.

Closing date is April 9.

221 mutual funds have positions, up from 219 last year.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs